Bailard’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,233
| Closed | -$56.1K | – | 765 |
|
|
2024
Q1 | $56.1K | Sell |
13,233
-6,487
| -33% | -$27.5K | ﹤0.01% | 727 |
|
|
2023
Q4 | $106K | Buy |
+19,720
| New | +$106K | ﹤0.01% | 691 |
|
|
2022
Q3 | – | Sell |
-26,854
| Closed | -$97K | – | 703 |
|
|
2022
Q2 | $97K | Buy |
+26,854
| New | +$97K | ﹤0.01% | 652 |
|
|
2022
Q1 | – | Sell |
-14,700
| Closed | -$104K | – | 762 |
|
|
2021
Q4 | $104K | Buy |
+14,700
| New | +$104K | ﹤0.01% | 708 |
|
|
2020
Q4 | – | Sell |
-18,500
| Closed | -$56K | – | 649 |
|
|
2020
Q3 | $56K | Buy |
+18,500
| New | +$56K | ﹤0.01% | 545 |
|